Par14 interacts with the androgen receptor, augmenting both its transcriptional activity and prostate cancer proliferation.

Thus, Par14 plays a critical role in PCa progression, and its enhancing effects on AR signaling are likely to be involved in the underlying molecular mechanisms. These findings suggest Par14 to be a promising therapeutic target for PCa.